ANDA
1 / 1
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
Tedor Pharma Services
PAO-08-23-CL-06Sep 26, 2023
Profounda, Inc.
Generics
FDA Grants Profounda Inc. Competitive Generic Therapy (CGT) Designation for planned ANDA filing of Minocycline Hydrochloride Microspheres, 1 mg
Profounda, Inc.
PR-M10-18-NI-014Oct 03, 2018
FDA
Breckenridge Wins ANDA for Azacitidine
Steve Kuehn
Nice Insight
PAO-M07-17-NI-001Jul 03, 2017
1 / 1